Our chief science officer, Barbara Madej, RPH, shares an important reminder: medications used to treat Alzheimer’s disease don’t just affect the brain—they can significantly impact oral health, too. From dry mouth and bruxism to taste changes and excessive salivation, understanding these drug-induced oral risks is essential for providing safer, more compassionate care.

Quick facts about Donepezil that dentists should know before treatment and prescribing.

Quick facts about Rivastigmine that dentists should know before treatment and prescribing.